Current Appointments & Affiliations
Wellcome Clinical Distinguished Professor of Medicine
·
2022 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Professor of Medicine
·
2017 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2007 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Journal Article Blood · September 5, 2024 Although initial therapy of mantle cell lymphoma (MCL) is not standardized, bendamustine plus rituximab (BR) is commonly used in older patients. Rituximab (R) maintenance after induction is often used. Thus, the open-label, randomized phase 2 ECOG-ACRIN Ca ... Full text Link to item CitePlatelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular Events.
Journal Article Arterioscler Thromb Vasc Biol · February 2024 BACKGROUND: Identifying patients with the optimal risk:benefit for ticagrelor is challenging. The aim was to identify ticagrelor-responsive platelet transcripts as biomarkers of platelet function and cardiovascular risk. METHODS: Healthy volunteers (n=58, ... Full text Link to item CiteLeukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL).
Journal Article Cold Spring Harb Mol Case Stud · December 2023 Diffuse large B-cell lymphoma (DLBCL) is a heterogenous group of lymphoid malignancies. Based on gene expression profiling, it has been subdivided into germinal center (GC)-derived and activated B-cell (ABC) types. Advances in molecular methodologies have ... Full text Link to item CiteRecent Grants
R01: Genetic Origins of Adverse Outcomes in African Americans with Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2028Clinical and Genetic of Monomorphic Epitheliotropic Intestinal T Cell Lymphoma
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2027Defining and exploiting EBV-infected cell heterogeneity in non-Hodgkin lymphomas
ResearchCo Investigator · Awarded by National Cancer Institute · 2022 - 2027View All Grants
Education, Training & Certifications
Northwestern University ·
1999
M.D.